FIELD: medicine, pharmaceutics.
SUBSTANCE: application describes prodrugs being 2-amino-6-({[2-(4-chlorophenyl)-1,3-thiazol-4-yl]methyl}thio)-4-[4-(2-hydroxyethoxy)-phenyl]pyridine-3,5-dicarbonitryl derivatives, and a method for preparing them.
EFFECT: invention can find application in treating and/or preventing cardiovascular diseases.
8 cl, 4 tbl, 18 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DIPEPTIDE PRODRUG, ITS APPLICATION AND MEDICINE | 2013 |
|
RU2629558C2 |
| REPLACED DIHYDROPYRAZOLONES AS INHIBITORS OF HIF-PROLYL-4-HYDROXYLASE | 2009 |
|
RU2509080C9 |
| SUBSTITUTED DIHYDROPYRAZOLONES FOR TREATING CARDIOVASCULAR AND HEMATOLOGIC DISEASES, USE THEREOF, DRUG AND METHOD OF TREATING AND/OR PREVENTING | 2012 |
|
RU2611012C2 |
| PIPERIDINYLPYRAZOLOPYRIMIDINONES AND USE THEREOF | 2015 |
|
RU2713937C2 |
| NEW CYCLOPENTA[B]BENZOFURANYL DERIVATIVES AND APPLICATION THEREOF | 2005 |
|
RU2415847C9 |
| METHOD OF PRODUCING 5-HYDROXYALKYL-SUBSTITUTED DERIVATIVES OF 1-PHENYL-1,2,4-TRIAZOLE | 2017 |
|
RU2742885C2 |
| SUBSTITUTED OXOPYRIDINE DERIVATIVE | 2019 |
|
RU2792645C2 |
| SUBSTITUTED 4-ARYL-1,4-DIHYDRO-1,6-NAPHTHYRIDINE AMIDES AND USE THEREOF | 2008 |
|
RU2470932C9 |
| DERIVATIVES OF PYRIMIDINONE AND PHARMACEUTICAL COMPOSITION ON THEIR BASIS, WHICH HAS PROPERTIES OF HUMAN NEUTROPHIL ELASTASE INHIBITOR | 2003 |
|
RU2376295C9 |
| SUBSTITUTED 3-PHENYLPROPIONIC ACIDS AND USING THEM | 2010 |
|
RU2553263C2 |
